0001179110-16-017212.txt : 20160105
0001179110-16-017212.hdr.sgml : 20160105
20160105183211
ACCESSION NUMBER: 0001179110-16-017212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160101
FILED AS OF DATE: 20160105
DATE AS OF CHANGE: 20160105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morenstein Scott D
CENTRAL INDEX KEY: 0001576113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 161324542
MAIL ADDRESS:
STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP
STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
edgar.xml
FORM 4 -
X0306
4
2016-01-01
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001576113
Morenstein Scott D
C/O CAXTON ALTERNATIVE MANAGEMENT
1330 6TH AVENUE, 20TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock
2016-01-01
4
A
0
17857
0
A
17857
D
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
/s/ Scott D. Morenstein
2016-01-05